• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeoVax Labs, Inc. - Common Stock (NQ:GOVX)

0.6007 +0.0407 (+7.27%)
Streaming Delayed Price Updated: 3:47 PM EDT, Oct 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about GeoVax Labs, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
GeoVax Leadership to Participate in Key European Meetings to Advance Partnering Discussions
October 13, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
GeoVax Leadership to Participate in Key European Meetings to Advance Partnering Discussions
October 13, 2025
Via TheNewswire.com
GeoVax to Present COVID-19 Vaccine Data at World Vaccine Congress Europe 2025
October 09, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
GeoVax to Present COVID-19 Vaccine Data at World Vaccine Congress Europe 2025
October 09, 2025
Via TheNewswire.com
GeoVax to Participate in the 4th Annual ROTH Healthcare Opportunities Conference
October 07, 2025
Via TheNewswire.com
GeoVax to Sponsor the 2025 Dr. David Satcher Global Health Equity Summit
October 01, 2025
Via TheNewswire.com
GeoVax Expands Gedeptin(R) Development to Additional Solid Tumor Indications
September 24, 2025
Via TheNewswire.com
GeoVax Reaffirms Commitment to Evidence-Based Vaccine Safety and Development of GEO-CM04S1 for Vulnerable Populations
September 22, 2025
Via TheNewswire.com
GeoVax to Present CM04S1 Clinical Progress at the Emerging Growth Conference
September 18, 2025
Via TheNewswire.com
GeoVax to Participate in the 4th Annual ROTH Healthcare Opportunities Conference
October 07, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
GeoVax to Sponsor the 2025 Dr. David Satcher Global Health Equity Summit
October 01, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
GeoVax Labs Announces $2.5 Million Registered Direct Offering
September 30, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
GeoVax Labs Announces $2.5 Million Registered Direct Offering
September 30, 2025
Via TheNewswire.com
Topics Regulatory Compliance
GeoVax to Present Multi-Antigen COVID-19 Vaccine Clinical Data at September International Scientific Conferences
September 08, 2025
Via TheNewswire.com
GeoVax to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 03, 2025
Via TheNewswire.com
GeoVax Announces Allowance of Patent Protecting Multi-Antigen COVID-19 Vaccine Constructs
August 20, 2025
Via TheNewswire.com
Topics Intellectual Property
GeoVax Comments on U.S. America First Global Health Strategy and Highlights Company's Role in Advancing American Innovation, Pandemic Preparedness, and Global Health Security
September 29, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Economy
GeoVax Comments on U.S. America First Global Health Strategy and Highlights Company's Role in Advancing American Innovation, Pandemic Preparedness, and Global Health Security
September 29, 2025
Via TheNewswire.com
Topics Economy
GeoVax Expands Gedeptin(R) Development to Additional Solid Tumor Indications
September 24, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
GeoVax Reaffirms Commitment to Evidence-Based Vaccine Safety and Development of GEO-CM04S1 for Vulnerable Populations
September 22, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
GeoVax to Present CM04S1 Clinical Progress at the Emerging Growth Conference
September 18, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
GeoVax to Present at the Emerging Growth Conference on August 20, 2025
August 18, 2025
Via TheNewswire.com
GeoVax Showcases Positive Phase 2 Data for GEO-CM04S1 in CLL Patients at the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Conference
September 15, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
GeoVax Showcases Positive Phase 2 Data for GEO-CM04S1 in CLL Patients at the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Conference
September 15, 2025
Via TheNewswire.com
GeoVax Showcases Promising GEO-CM04S1 Clinical Data at the European Society of Clinical Microbiology and Infectious Disease (ESCMID) Conference
September 12, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
GeoVax Showcases Promising GEO-CM04S1 Clinical Data at the European Society of Clinical Microbiology and Infectious Disease (ESCMID) Conference
September 12, 2025
Via TheNewswire.com
GeoVax to Present Multi-Antigen COVID-19 Vaccine Clinical Data at September International Scientific Conferences
September 08, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
GeoVax to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 03, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
GeoVax Announces Allowance of Patent Protecting Multi-Antigen COVID-19 Vaccine Constructs
August 20, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property
GeoVax to Present at the Emerging Growth Conference on August 20, 2025
August 18, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Recent Quotes
View More
Symbol Price Change (%)
GOOG  245.30
+0.66 (0.27%)
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap